MARPAI ANNOUNCES KEY FINANCIAL AGREEMENTS
Marpai executes amendment with AXA delaying payment obligations and secures $1.7 million in revenue-based financing from Libertas Funding, LLC.
NEW YORK, Feb. 8, 2024 /PRNewswire/ — Marpai, Inc. (“Marpai” or the “Company”) (Nasdaq: MRAI), an independent national Third-Party Administration company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent, healthcare, today announced two key financing agreements.
Related news for (MRAI)
- MARPAI REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
- MARPAI TO HOST WEBCAST ON AUGUST 14, 2025 TO DISCUSS SECOND QUARTER 2025 FINANCIAL RESULTS
- MARPAIRX REVOLUTIONIZES PHARMACY BENEFITS WITH UNPRECEDENTED TRANSPARENCY AND SAVINGS
- MARPAI REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
- MARPAI HIRES DALLAS SCRIP AS CHIEF OPERATING OFFICER